Karl Erik Hellström

Karl Erik Hellström

Nessuna posizione attualmente

Health Technology

Profilo

Dr. Hellström received his M.D.
and Ph.D.
degrees from Karolinska Institute in Stockholm, Sweden, initially working in the area of tumor biology with an emphasis on immunogenetics.
As a student of George Klein, he was a member of the team that showed, for the first time, a tumor-destructive immune response to an animal's own autologous tumor.
After being recruited to the faculty of the University of Washington Medical School in 1966, Karl Erik Hellström and his wife, Dr. Ingegerd Hellström became internationally known after they reported that there is a T-lymphocyte-mediated immune response to human tumors, a discovery that opened new avenues for research and development of cancer therapy.

Precedenti posizioni note di Karl Erik Hellström

SocietàPosizioneFine
MARKER THERAPEUTICS, INC. Direttore/Membro del Consiglio 05/12/2005
SEAGEN INC. Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Karl Erik Hellström

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Karl Erik Hellström

Società collegate

Società quotate in Borsa1
MARKER THERAPEUTICS, INC.

Health Technology

Aziende private1

Health Technology

  1. Borsa valori
  2. Insiders
  3. Karl Erik Hellström